Close

Rating History for Par Pharmaceutical (PRX) by UBS

More Stocks Rated by UBS | Latest Ratings for PRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/8/2012 N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 50.02
(49.98)		 -0.08% Details